• Change Agents appointed Eric Weisblum an independent director on October 14, 2026, effective October 12, 2026.
• Weisblum will serve on the audit, compensation, and nominating and corporate governance committees.
• He founded biopharmaceutical company Silo Pharma, serving as CEO since 2020, with prior investment banking and capital markets experience.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Change Agents Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-110039), on October 16, 2026, and is solely responsible for the information contained therein.